NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 83 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is 473.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $172,000 | +258.3% | 336,414 | +305.6% | 0.01% | +400.0% |
| Q1 2017 | $48,000 | +380.0% | 82,943 | +449.8% | 0.00% | – |
| Q4 2016 | $10,000 | -78.7% | 15,086 | -83.0% | 0.00% | -100.0% |
| Q2 2016 | $47,000 | -65.9% | 88,831 | -14.7% | 0.00% | -50.0% |
| Q4 2015 | $138,000 | +53.3% | 104,085 | +85.2% | 0.00% | 0.0% |
| Q2 2015 | $90,000 | +34.3% | 56,207 | +33.1% | 0.00% | +100.0% |
| Q1 2015 | $67,000 | +204.5% | 42,244 | +259.6% | 0.00% | – |
| Q4 2014 | $22,000 | -78.8% | 11,747 | -83.3% | 0.00% | -100.0% |
| Q2 2014 | $104,000 | +30.0% | 70,153 | +63.4% | 0.00% | +100.0% |
| Q1 2014 | $80,000 | +33.3% | 42,932 | +48.1% | 0.00% | 0.0% |
| Q4 2013 | $60,000 | -52.8% | 28,996 | -39.5% | 0.00% | -50.0% |
| Q3 2013 | $127,000 | – | 47,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 15,046,431 | $19,861,000 | 4.55% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 6,702,002 | $8,847,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $38,000 | 0.03% |
| Hudock, Inc. | 27,500 | $36,000 | 0.02% |
| NOMURA HOLDINGS INC | 4,631,059 | $6,250,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 491,780 | $649,000 | 0.02% |
| Stratos Wealth Partners, LTD. | 45,535 | $60,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $24,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 71,463 | $94,000 | 0.01% |
| SII INVESTMENTS INC/WI | 63,115 | $83,000 | 0.01% |